Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir.

Georgel AF, Cayet D, Pizzorno A, Rosa-Calatrava M, Paget C, Sencio V, Dubuisson J, Trottein F, Sirard JC, Carnoy C.

Antiviral Res. 2019 Aug;168:28-35. doi: 10.1016/j.antiviral.2019.05.002. Epub 2019 May 9.

PMID:
31078648
2.

Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia.

Matarazzo L, Casilag F, Porte R, Wallet F, Cayet D, Faveeuw C, Carnoy C, Sirard JC.

Front Immunol. 2019 Apr 9;10:723. doi: 10.3389/fimmu.2019.00723. eCollection 2019.

3.

Development and Evaluation of a Hybrid Course in Clinical Virology at a Faculty of Pharmacy in Lille, France.

Goffard A, Odou P, Aliouat EM, Aliouat-Denis CM, Carnoy C, Décaudin B, Damien C, Hamoudi M, Pinçon C, Quelennec K, Zanetti S, Ravaux P, Standaert A.

JMIR Med Educ. 2019 Apr 11;5(1):e10766. doi: 10.2196/10766.

4.

Compartmentalized Antimicrobial Defenses in Response to Flagellin.

Vijayan A, Rumbo M, Carnoy C, Sirard JC.

Trends Microbiol. 2018 May;26(5):423-435. doi: 10.1016/j.tim.2017.10.008. Epub 2017 Nov 22. Review.

5.

Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Porte R, Van Maele L, Muñoz-Wolf N, Foligné B, Dumoutier L, Tabareau J, Cayet D, Gosset P, Jonckheere N, Van Seuningen I, Chabalgoity JA, Simonet M, Lamkanfi M, Renauld JC, Sirard JC, Carnoy C.

Infect Immun. 2017 Jan 26;85(2). pii: e00806-16. doi: 10.1128/IAI.00806-16. Print 2017 Feb.

6.

A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections.

Porte R, Fougeron D, Muñoz-Wolf N, Tabareau J, Georgel AF, Wallet F, Paget C, Trottein F, Chabalgoity JA, Carnoy C, Sirard JC.

Antimicrob Agents Chemother. 2015 Oct;59(10):6064-72. doi: 10.1128/AAC.01210-15. Epub 2015 Jul 20.

7.

Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.

Goubard A, Loïez C, Abe J, Fichel C, Herwegh S, Faveeuw C, Porte R, Cayet D, Sebbane F, Penet S, Foligné B, Desreumaux P, Saito H, Sirard JC, Simonet M, Carnoy C.

Infect Immun. 2015 May;83(5):2053-64. doi: 10.1128/IAI.02339-14. Epub 2015 Mar 9.

8.

Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection.

Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E, Chabalgoity JA, Renauld JC, Eberl G, Benecke AG, Trottein F, Faveeuw C, Sirard JC.

J Infect Dis. 2014 Aug 1;210(3):493-503. doi: 10.1093/infdis/jiu106. Epub 2014 Feb 26.

PMID:
24577508
9.

Chronic ingestion of cadmium and lead alters the bioavailability of essential and heavy metals, gene expression pathways and genotoxicity in mouse intestine.

Breton J, Le Clère K, Daniel C, Sauty M, Nakab L, Chassat T, Dewulf J, Penet S, Carnoy C, Thomas P, Pot B, Nesslany F, Foligné B.

Arch Toxicol. 2013 Oct;87(10):1787-95. doi: 10.1007/s00204-013-1032-6. Epub 2013 Mar 17.

PMID:
23503628
10.

Xer recombinase and genome integrity in Helicobacter pylori, a pathogen without topoisomerase IV.

Debowski AW, Carnoy C, Verbrugghe P, Nilsson HO, Gauntlett JC, Fulurija A, Camilleri T, Berg DE, Marshall BJ, Benghezal M.

PLoS One. 2012;7(4):e33310. doi: 10.1371/journal.pone.0033310. Epub 2012 Apr 12. Erratum in: PLoS One. 2012;7(7): 10.1371/annotation/f5629404-e0e6-4cc1-9d76-ab16238a48c0.

11.

First case of postaneurysmal prosthetic vascular infection due to a nonsuperantigenic Yersinia pseudotuberculosis strain.

Loïez C, Carnoy C, Decoene C, Pradel E, Fichel C, Courcol R, Wallet F.

J Clin Microbiol. 2010 Aug;48(8):3024-6. doi: 10.1128/JCM.00671-10. Epub 2010 Jun 23.

12.

TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.

Van Maele L, Carnoy C, Cayet D, Songhet P, Dumoutier L, Ferrero I, Janot L, Erard F, Bertout J, Leger H, Sebbane F, Benecke A, Renauld JC, Hardt WD, Ryffel B, Sirard JC.

J Immunol. 2010 Jul 15;185(2):1177-85. doi: 10.4049/jimmunol.1000115. Epub 2010 Jun 21.

13.

The dif/Xer recombination systems in proteobacteria.

Carnoy C, Roten CA.

PLoS One. 2009 Sep 3;4(9):e6531. doi: 10.1371/journal.pone.0006531.

14.

Development and use of an internal positive control for detection of Bordetella pertussis by PCR.

Herwegh S, Carnoy C, Wallet F, Loïez C, Courcol RJ.

J Clin Microbiol. 2005 May;43(5):2462-4.

15.

Linkage of the horizontally acquired ypm and pil genes in Yersinia pseudotuberculosis.

Collyn F, Fukushima H, Carnoy C, Simonet M, Vincent P.

Infect Immun. 2005 Apr;73(4):2556-8.

16.

Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence.

Selvarangan R, Goluszko P, Singhal J, Carnoy C, Moseley S, Hudson B, Nowicki S, Nowicki B.

Infect Immun. 2004 Aug;72(8):4827-35.

17.

Impact of the Yersinia pseudotuberculosis-derived mitogen (YPM) on the murine immune system.

Carnoy C, Loiez C, Faveeuw C, Grangette C, Desreumaux P, Simonet M.

Adv Exp Med Biol. 2003;529:133-5. No abstract available.

PMID:
12756744
18.

The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.

Carnoy C, Floquet S, Marceau M, Sebbane F, Haentjens-Herwegh S, Devalckenaere A, Simonet M.

J Bacteriol. 2002 Aug;184(16):4489-99.

19.

Superantigen bacterial toxins: state of the art.

Müller-Alouf H, Carnoy C, Simonet M, Alouf JE.

Toxicon. 2001 Nov;39(11):1691-701. Review.

PMID:
11595632
20.

The superantigenic toxin of Yersinia pseudotuberculosis: a novel virulence factor?

Carnoy C, Müller-Alouf H, Desreumaux P, Mullet C, Grangette C, Simonet M.

Int J Med Microbiol. 2000 Oct;290(4-5):477-82. Review.

PMID:
11111929
21.

Structural and functional lesions in brush border of human polarized intestinal Caco-2/TC7 cells infected by members of the Afa/Dr diffusely adhering family of Escherichia coli.

Peiffer I, Guignot J, Barbat A, Carnoy C, Moseley SL, Nowicki BJ, Servin AL, Bernet-Camard MF.

Infect Immun. 2000 Oct;68(10):5979-90.

23.

Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.

Carnoy C, Mullet C, Müller-Alouf H, Leteurtre E, Simonet M.

Infect Immun. 2000 May;68(5):2553-9.

24.
25.

Adhesion of Pseudomonas aeruginosa to respiratory mucins and expression of mucin-binding proteins are increased by limiting iron during growth.

Scharfman A, Kroczynski H, Carnoy C, Van Brussel E, Lamblin G, Ramphal R, Roussel P.

Infect Immun. 1996 Dec;64(12):5417-20.

26.

Pseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins.

Carnoy C, Scharfman A, Van Brussel E, Lamblin G, Ramphal R, Roussel P.

Infect Immun. 1994 May;62(5):1896-900.

27.

Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.

Carnoy C, Ramphal R, Scharfman A, Lo-Guidice JM, Houdret N, Klein A, Galabert C, Lamblin G, Roussel P.

Am J Respir Cell Mol Biol. 1993 Sep;9(3):323-34.

PMID:
8398170
28.
29.
30.

The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins.

Klein A, Carnoy C, Wieruszeski JM, Strecker G, Strang AM, van Halbeek H, Roussel P, Lamblin G.

Biochemistry. 1992 Jul 7;31(26):6152-65.

PMID:
1627559
31.

Arylneuraminidase activity of Pseudomonas aeruginosa does not degrade natural substrates such as human respiratory mucins.

Scharfman A, Ramphal R, Neut C, Carnoy C, Lamblin G, Roussel P.

Infect Immun. 1991 Nov;59(11):4283-5.

34.

Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Gal beta 1-3GlcNAc) or type 2 (Gal beta 1-4GlcNAc) disaccharide units.

Ramphal R, Carnoy C, Fievre S, Michalski JC, Houdret N, Lamblin G, Strecker G, Roussel P.

Infect Immun. 1991 Feb;59(2):700-4.

Supplemental Content

Loading ...
Support Center